Cargando…
A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) has become a global health issue of wide concern due to its high prevalence and poor therapeutic efficacy. Both tumor doubling time (TDT) and immune status are closely related to the prognosis of HCC patients. However, the association between TDT-related ge...
Autores principales: | Zhang, Genhao, Su, Lisa, Lv, Xianping, Yang, Qiankun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502295/ https://www.ncbi.nlm.nih.gov/pubmed/34627241 http://dx.doi.org/10.1186/s12935-021-02227-w |
Ejemplares similares
-
A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022) -
A Novel Five-Gene Signature for Prognosis Prediction in Hepatocellular Carcinoma
por: Su, Lisa, et al.
Publicado: (2021) -
Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022) -
Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
por: Zheng, Qiuxian, et al.
Publicado: (2021) -
Endoplasmic Reticulum Stress-Related Signature for Predicting Prognosis and Immune Features in Hepatocellular Carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)